Amino Acid Supplementation in Recovery From Severe Burns (ExAA)
Primary Purpose
Burn Injury
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
EAA Supplementation + Exercise Training
Placebo + Exercise Training
Sponsored by
About this trial
This is an interventional basic science trial for Burn Injury focused on measuring burn injury, children, nutrition, lipid metabolism, insulin sensitivity, amino acids
Eligibility Criteria
Inclusion Criteria:
- Male or female
- 7-17 years old
- Body weight >20 kg (based on blood requirements)
- ≥30% Total Body Surface Area (TBSA)
- Wounds 95% healed
Exclusion Criteria:
- Respiratory insufficiency
- Multiple fractures
- History of Cancer in the last 5 years
- Diabetes Mellitus
- Bilirubin > 3 mg/dl
- Associated head injuries requiring specific therapy
- Associated injuries to chest or abdomen requiring surgery
- Serum creatinine > 3 mg/dl after fluid resuscitation
- Receipt of any experimental drug other than the ones supplied within two months of this study
- Any metal in body including rods, cardiac defibrillator, pacemakers, etc
- Orthopedic casting which would prevent placement of patient in MRI machine
- Hepatitis
- Abnormal EKG
- Electrical burns
- Patients unable to lie still without heavy sedation will be excluded from MRI portion.
Sites / Locations
- Shriners Hospitals for Children
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Placebo Comparator
Arm Label
EAA Supplementation + Exercise Training
Placebo + Exercise Training
Arm Description
Drink an amino acid supplementation during exercise training.
Drink a placebo supplementation during exercise training.
Outcomes
Primary Outcome Measures
Lean Muscle Mass
Is the total weight of your body minus all the weight due to your fat mass. It is measured in kilograms by dual X-ray absorptiometry scan.
Secondary Outcome Measures
whole body lipolysis rate
A euglycemic-hyperinsulinemic clamp is performed over the last 2hr of the 4-hr isotope infusion. It is measured in μmol/kg body weight/min
Hepatic glucose release rate and whole body glucose uptake rate
A primed, constant (0.44 μmol/kg/min) infusion of [6,6-2H2]-glucose is used for glucose kinetics. A euglycemic-hyperinsulinemic clamp is performed over the last 2h of the 4-hr isotope infusion.It is measured in μmol/kg body weight/min.
Full Information
NCT ID
NCT01618630
First Posted
May 30, 2012
Last Updated
December 7, 2018
Sponsor
The University of Texas Medical Branch, Galveston
Collaborators
Shriners Hospitals for Children
1. Study Identification
Unique Protocol Identification Number
NCT01618630
Brief Title
Amino Acid Supplementation in Recovery From Severe Burns
Acronym
ExAA
Official Title
Amino Acid Benefits in Pediatric Burn Patients Who Participate in Exercise.
Study Type
Interventional
2. Study Status
Record Verification Date
November 2018
Overall Recruitment Status
Completed
Study Start Date
May 2012 (undefined)
Primary Completion Date
December 5, 2016 (Actual)
Study Completion Date
December 5, 2017 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
The University of Texas Medical Branch, Galveston
Collaborators
Shriners Hospitals for Children
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Exercise during recovery is now Standard of Care at Shriners Hospital for Children Galveston, since positive effects of exercise training were found on lean body mass and recovery after burns. Essential amino acids (EAA) effective in healthy individuals.Thus, EAA supplementation in children recovering from burns, may potentially augment the effects of exercise by increase muscle mass, improve muscle fat oxidation, reduce tissue fat, and possibly improve insulin resistance.
Detailed Description
Severe burns result in persistent and extensive fat deposition in liver and muscle tissue. This may be related to the prolonged insulin resistance observed following burn. In this study the investigators will test the hypothesis that essential amino acids act in synergy with exercise to improve liver steatosis and muscle lipid metabolism, and thus also affect insulin sensitivity. Children with burns will participate in six weeks of exercise training with/without amino acid supplementation. Before and after the intervention, measurements will be done to determine muscle and liver fat content, muscle fat and protein metabolism, and insulin sensitivity.
We will prospectively enroll 40 children with ≥30% of their total body surface area (TBSA) burned. The age range will be 7-17 years. Children will be recruited from Shriners Hospitals for Children (SHC)-Galveston. Burned children will be randomized to undergo an exercise program in combination with daily intake of EAA (n=20) or a placebo drink (n=20). The exercise program and daily intake of AA will begin within the first week of discharge from the burn ICU (approximately 1-3 months post burn, when the patient's wounds are 95% healed). The definition of 95% healed is 7 days after the final autografting procedure. We anticipate enrolling 10 children per year for 4 years. Only children meeting the inclusion and exclusion criteria specified in the Human Subjects Section will be enrolled.
Nutritional Supplement: The nutritional supplement will be administered at a dose of 0.18 g/kg body weight of amino acids two times per day with the following composition: 3% histidine, 9% isoleucine, 36% leucine, 17% lysine, 4% methionine, 5% phenylalanine, 10% threonine, 7% valine, and 10% arginine. The dose and choice of amino acids is based on our preliminary data. Each dose is about 0.03 g/kg body weight higher than what has been shown effective in adults, as children have higher protein needs. We have shown that only EAA are needed to affect muscle protein synthesis and lean mass. Thus the amount given (g or kcal) can be restricted. As in our preliminary studies, we will include arginine in the EAA mixture, since arginine may have unique anabolic effects (55; 86). Placebo will consist of a mixture of inert components (sucralose and other pharmaceutical excipients). The supplement will be taken in two daily doses in the form of drinks (total daily dose of i.e., 0.30 g/kg body weight total per day), and intake recorded in a diary. The first dose will be taken between breakfast and lunch, and the second between lunch and dinner. For the children exercising before lunch, the first dose of EAA will be ingested immediately after exercise. Correspondingly, for children exercising after lunch, the second EAA dose of the day will be ingested immediately after exercise. If the child forgets to take one of the drinks during the day, he/she may take the second one between dinner and bedtime. During the weekends, parents/caregivers are instructed to take the dosage around the same time.
Data Analysis and Interpretation. To determine effects of amino acids on fat and muscle lipid stores, changes from pre- to post intervention in the two groups will be compared using ANCOVA. From the preliminary data, we expect that amino acids will decrease liver and plasma lipids.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Burn Injury
Keywords
burn injury, children, nutrition, lipid metabolism, insulin sensitivity, amino acids
7. Study Design
Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
20 (Actual)
8. Arms, Groups, and Interventions
Arm Title
EAA Supplementation + Exercise Training
Arm Type
Experimental
Arm Description
Drink an amino acid supplementation during exercise training.
Arm Title
Placebo + Exercise Training
Arm Type
Placebo Comparator
Arm Description
Drink a placebo supplementation during exercise training.
Intervention Type
Dietary Supplement
Intervention Name(s)
EAA Supplementation + Exercise Training
Intervention Description
Amino acids in drinks between meals for exercise training period.
Intervention Type
Dietary Supplement
Intervention Name(s)
Placebo + Exercise Training
Intervention Description
Placebo supplementation as drinks in between meals for exercise training period.
Primary Outcome Measure Information:
Title
Lean Muscle Mass
Description
Is the total weight of your body minus all the weight due to your fat mass. It is measured in kilograms by dual X-ray absorptiometry scan.
Time Frame
It is the change in time, from baseline until post exercise. Baseline is within the first week of discharge from the burn ICU, approximately 1-3 months post burn. Exercise training is 6-12 weeks.
Secondary Outcome Measure Information:
Title
whole body lipolysis rate
Description
A euglycemic-hyperinsulinemic clamp is performed over the last 2hr of the 4-hr isotope infusion. It is measured in μmol/kg body weight/min
Time Frame
It is the change in time, from baseline until post exercise. Baseline is within the first week of discharge from the burn ICU, approximately 1-3 months post burn. Exercise training is 6-12 weeks.
Title
Hepatic glucose release rate and whole body glucose uptake rate
Description
A primed, constant (0.44 μmol/kg/min) infusion of [6,6-2H2]-glucose is used for glucose kinetics. A euglycemic-hyperinsulinemic clamp is performed over the last 2h of the 4-hr isotope infusion.It is measured in μmol/kg body weight/min.
Time Frame
It is the change in time, from baseline until post exercise. Baseline is within the first week of discharge from the burn ICU, approximately 1-3 months post burn. Exercise training is 6-12 weeks.
10. Eligibility
Sex
All
Minimum Age & Unit of Time
7 Years
Maximum Age & Unit of Time
17 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Male or female
7-17 years old
Body weight >20 kg (based on blood requirements)
≥30% Total Body Surface Area (TBSA)
Wounds 95% healed
Exclusion Criteria:
Respiratory insufficiency
Multiple fractures
History of Cancer in the last 5 years
Diabetes Mellitus
Bilirubin > 3 mg/dl
Associated head injuries requiring specific therapy
Associated injuries to chest or abdomen requiring surgery
Serum creatinine > 3 mg/dl after fluid resuscitation
Receipt of any experimental drug other than the ones supplied within two months of this study
Any metal in body including rods, cardiac defibrillator, pacemakers, etc
Orthopedic casting which would prevent placement of patient in MRI machine
Hepatitis
Abnormal EKG
Electrical burns
Patients unable to lie still without heavy sedation will be excluded from MRI portion.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Oscar E Suman, PhD
Organizational Affiliation
UTMB, Shriners Hospitals for Children
Official's Role
Principal Investigator
Facility Information:
Facility Name
Shriners Hospitals for Children
City
Galveston
State/Province
Texas
ZIP/Postal Code
77550
Country
United States
12. IPD Sharing Statement
Learn more about this trial
Amino Acid Supplementation in Recovery From Severe Burns
We'll reach out to this number within 24 hrs